Device Trial Radar · NCT07834658
Effects of Transcutaneous Tibial and Auricular Vagus Nerve Stimulation in Females With Primary Dysmenorrhea
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
66
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Jun 30, 2027
Study completion Jul 31, 2027
Sponsor
- Lead sponsor
- Riphah International UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 14 years, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary dysmenorrhea is a common gynecological condition characterized by painful menstrual cramps that can negatively affect daily activities and quality of life. Non-invasive neuromodulation techniques, including Transcutaneous Tibial Nerve Stimulation (TTNS) and Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), have shown potential for pain management and modulation of autonomic nervous system function. However, limited evidence exists regarding the comparative and combined effects of these interventions. This randomized controlled trial aims to evaluate the comparative and combined effects of TTNS and taVNS on pain, autonomic function, menstrual symptoms, and NSAID consumption in females with primary dysmenorrhea. Eligible participants will be randomly assigned to one of four groups: TTNS, taVNS, combined TTNS + taVNS, or sham stimulation. Outcome measures will be assessed before and after the intervention period by a blinded assessor.
Conditions
- Primary Dysmenorrhea (PD)
Interventions
Transcutaneous Tibial Nerve Stimulation (TTNS)Device
Electrical stimulation will be delivered through a TENS device using surface electrodes placed over the posterior tibial nerve for 30 mins according to the study protocol for the management of primary dysmenorrhea. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.
Transcutaneous Auricular Vagus Nerve Stimulation (TaVNS)Device
Electrical stimulation delivered through a TENS device using surface electrodes placed on the auricular branch of the vagus nerve for 30 mins according to the study protocol for the management of primary dysmenorrhea. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.
TTNS+TaVNSDevice
Electrical stimulation delivered through a TENS device to both the posterior tibial nerve and the auricular branch of the vagus nerve sequentially according to the study protocol. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.
Sham StimulationDevice
Sham stimulation delivered using the same TENS device and electrode placement as the active intervention but without therapeutic electrical stimulation. The intervention will be applied for 5 consecutive days, including 2 days before and 3 days during the mensturation period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dysmenorrhea Severity - WaLIDD ScoreTime frame: Baseline, 4th Week, 8th Week , and 12th Week
- Pain Intensity - Numeric Pain Rating Scale (NPRS)Time frame: Baseline, 4th Week, 8th Week , and 12th Week
- Autonomic Function - Heart Rate Variability (RMSSD)Time frame: Baseline, 4th Week, 8th Week , and 12th Week
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Postgraduate Lab of Riphah International University
Islamabad, Fedral Teritory, Pakistan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.